| 1 |
Stability indicating RP-HPLC method for determination and validation of repaglinide in pharmaceutical dosage form |
|
| | Sharma, M.C., Sharma, S. | | | International Journal of ChemTech Research. 2011; 3(1): 210-216 | | | [Pubmed] [Google Scholar] | | | 2 |
Determination of repaglinide in pharmaceutical formulations by RP-HPLC method |
|
| | Prameela Rani, A., Bala Sekaran, C., Archana, N., Siva Teja, P., Aruna, B. | | | Journal of Applied Sciences Research. 2009; 5(10): 1500-1504 | | | [Pubmed] [Google Scholar] | | | 3 |
Estimation of repaglinide in bulk and tablet dosage forms by HPTLC method |
|
| | Jiladia, M.A., Pandya, S.S. | | | International Journal of Pharmacy and Pharmaceutical Sciences. 2009; 1(Suppl 1): 141-144 | | | [Pubmed] [Google Scholar] | | | 4 |
Enzymatic method for the determination of Perindopril erbumine and Repaglinide in bulk and dosage forms |
|
| | Prameela Rani, A., Bala Sekaran, C., Srilakshmi, Ch. | | | Biomedical and Pharmacology Journal. 2009; 2(1): 91-94 | | | [Pubmed] [Google Scholar] | | | 5 |
A comparative study of first-derivative spectrophotometry and column high-performance liquid chromatography applied to the determination of repaglinide in tablets and for dissolution testing |
|
| | AlKhalidi, B.A., Shtaiwi, M., AlKhatib, H.S., Mohammad, M., Bustanji, Y. | | | Journal of AOAC International. 2008; 91(3): 530-535 | | | [Pubmed] [Google Scholar] | |
|
